Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice.
Saved in:
| Title: | Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice. |
|---|---|
| Authors: | Denroche HC; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Surgery, University of British Columbia, Vancouver, BC, Canada., Ng V; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Surgery, University of British Columbia, Vancouver, BC, Canada.; Integrated Nanotherapeutics Inc., Burnaby, BC, Canada., Velghe J; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Suen I; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Stanley L; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Surgery, University of British Columbia, Vancouver, BC, Canada., Nackiewicz D; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Komba M; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Surgery, University of British Columbia, Vancouver, BC, Canada., Dai DL; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Surgery, University of British Columbia, Vancouver, BC, Canada., Soukhatcheva G; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Surgery, University of British Columbia, Vancouver, BC, Canada., Chen S; Integrated Nanotherapeutics Inc., Burnaby, BC, Canada., Verchere CB; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Surgery, University of British Columbia, Vancouver, BC, Canada. bverchere@bcchr.ca.; Canucks for Kids Fund Childhood Diabetes Laboratories, BC Children's Hospital Research Institute, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. bverchere@bcchr.ca.; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada. bverchere@bcchr.ca. |
| Source: | Diabetologia [Diabetologia] 2026 Apr; Vol. 69 (4), pp. 987-999. Date of Electronic Publication: 2025 Dec 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
